¥1,487.00 ($9.42)

+11.00 (+0.75%)

Weekly Expected Move ±2.5%

¥1412 ¥1450 ¥1487 ¥1524 ¥1562

JPX · Healthcare · Medical - Devices · Tech Score Neutral · Power 60 · ¥13.5B mcap · 2M float · 0.564% daily turnover

Analysis Technicals Weather Peers

Revenue

$6.9B +16.4% ▲

5Y CAGR: +19.1%

Gross Profit

$4.7B +17.4% ▲

5Y CAGR: +20.7%

Operating Income

$1.8B +20.6% ▲

5Y CAGR: +29.1%

Net Income

$1.3B +29.7% ▲

5Y CAGR: +32.5%

EPS (Diluted)

$145.54 +29.6% ▲

5Y CAGR: +29.1%

EBITDA

$1.9B +21.3% ▲

5Y CAGR: +27.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.7B	$4.7B	$5.4B	$5.9B	$6.9B
YoY Growth	+28.7%	+25.5%	+15.9%	+10.0%	+16.4%
Cost of Revenue	$1.3B	$1.6B	$2.0B	$2.0B	$2.3B
Gross Profit	$2.5B	$3.0B	$3.5B	$4.0B	$4.7B
Gross Margin	66.2%	65.3%	63.9%	66.7%	67.3%
R&D Expenses	$25M	$31M	$27M	$21M	$0
SG&A Expenses	$1.8B	$2.0B	$2.4B	$2.4B	$2.8B
Operating Expenses	$1.8B	$2.1B	$2.4B	$2.5B	$2.8B
Operating Income	$646M	$951M	$1.0B	$1.5B	$1.8B
Operating Margin	17.4%	20.4%	18.8%	25.2%	26.2%
Interest Expense	$3M	$1M	$720K	$0	$0
Income Before Tax	$618M	$944M	$1.0B	$1.5B	$1.8B
Tax Expense	$197M	$334M	$373M	$458M	$499M
Net Income	$421M	$610M	$645M	$1.0B	$1.3B
Net Margin	11.3%	13.1%	11.9%	17.2%	19.2%
EPS (Diluted)	$50.01	$66.84	$70.63	$112.33	$145.54
EBITDA	$691M	$1.0B	$1.1B	$1.6B	$1.9B
Shares Outstanding	8M	9M	9M	9M	9M

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$1.5B	$1.9B	$1.3B	$1.8B	$1.8B	$2.5B	$1.8B	$2.5B
Cost of Revenue	$473M	$640M	$420M	$608M	$592M	$816M	$547M	$750M
Gross Profit	$981M	$1.3B	$913M	$1.2B	$1.3B	$1.7B	$1.3B	$1.8B
Gross Margin	67.4%	66.2%	68.5%	67.0%	67.9%	67.4%	70.0%	70.4%
R&D Expenses	$21M	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$653M	$632M	$591M	$723M	$901M	$1.1B	$773M	$1.2B
Operating Expenses	$700M	$632M	$591M	$723M	$901M	$1.1B	$773M	$1.2B
Operating Income	$281M	$623M	$322M	$512M	$353M	$614M	$503M	$601M
Operating Margin	19.3%	32.9%	24.1%	27.8%	19.1%	24.5%	27.6%	23.8%
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$261M	$644M	$317M	$509M	$357M	$620M	$508M	$604M
Tax Expense	$96M	$119M	$98M	$166M	$115M	$194M	$165M	$201M
Net Income	$165M	$525M	$219M	$343M	$242M	$426M	$343M	$403M
Net Margin	11.3%	27.7%	16.4%	18.6%	13.1%	17.0%	18.8%	15.9%
EPS (Diluted)	$18.06	$57.56	$23.94	$37.54	$26.50	$46.62	$37.59	$44.15
EBITDA	$283M	$659M	$333M	$529M	$379M	$635M	$521M	$627M
Shares Outstanding	9M	9M	9M	9M	9M	9M	9M	9M

7792.T JPX